These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2040799)

  • 41. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
    Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype.
    Karr RW; Gregersen PK; Obata F; Goldberg D; Maccari J; Alber C; Silver J
    J Immunol; 1986 Nov; 137(9):2886-90. PubMed ID: 3020127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
    Kuwana M; Medsger TA; Wright TM
    J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.
    Lombardi G; Barber L; Aichinger G; Heaton T; Sidhu S; Batchelor JR; Lechler RI
    J Immunol; 1991 Sep; 147(6):2034-40. PubMed ID: 1716292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.
    O'Sullivan D; Arrhenius T; Sidney J; Del Guercio MF; Albertson M; Wall M; Oseroff C; Southwood S; Colón SM; Gaeta FC
    J Immunol; 1991 Oct; 147(8):2663-9. PubMed ID: 1717570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
    Brawley JV; Concannon P
    J Exp Med; 1996 May; 183(5):2043-51. PubMed ID: 8642315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of three functional sites in alpha beta 1 DR of DRw13. All three sites are potentially involved in major histocompatibility complex-peptide interaction.
    Sterkers G; Tiercy JM; Zeliszewski D; Levy JP; Mach B
    Eur J Immunol; 1989 Sep; 19(9):1585-90. PubMed ID: 2529124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of residues involved in polymorphic antibody binding epitopes on HLA-DR molecules.
    Fu XT; Yu WY; Alber C; Benson C; Watts R; Nordwig H; Johnson JP; Knowles RW; Karr RW
    Hum Immunol; 1992 Jan; 33(1):47-56. PubMed ID: 1372304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.
    Olson RR; Reuter JJ; McNicholl J; Alber C; Klohe E; Callahan K; Siliciano RF; Karr RW
    Hum Immunol; 1994 Nov; 41(3):193-200. PubMed ID: 7868374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.
    De Magistris MT; Di Tommaso A; Domenighini M; Censini S; Tagliabue A; Oksenberg JR; Steinman L; Judd AK; O'Sullivan D; Rappuoli R
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2990-4. PubMed ID: 1313575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes.
    Young JA; Wilkinson D; Bodmer WF; Trowsdale J
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4929-33. PubMed ID: 3110774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.
    Lombardi G; Sidhu S; Batchelor JR; Lechler RI
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4190-4. PubMed ID: 2657745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition of the HLA class II-peptide complex by T-cell receptor: reversal of major histocompatibility complex restriction of a T-cell clone by a point mutation in the peptide determinant.
    Rothbard JB; Busch R; Lechler R; Trowsdale J; Lamb JR
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):553-64. PubMed ID: 2474172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alloreactive T cell recognition of the HLA-DR beta N-terminal polymorphic region.
    Ulrich RG; Atassi MZ
    Immunol Lett; 1989 Jun; 21(4):285-90. PubMed ID: 2570042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DR beta peptides block the antigen-specific response but not the alloresponse of a dual-reactive T-cell clone.
    Ulrich RG; Thomas JW; Miller GG; Atassi MZ
    Immunol Lett; 1990; 24(1):43-7. PubMed ID: 1695611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of HLA restriction by a point mutation in an antigenic peptide.
    Rothbard JB; Busch R; Bal V; Trowsdale J; Lechler RI; Lamb JR
    Int Immunol; 1989; 1(5):487-95. PubMed ID: 2489039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigen processing and presentation by a mouse macrophage-like cell line expressing human HLA class II molecules.
    Daubenberger C; Lang B; Nickel B; Willcox N; Melchers I
    Int Immunol; 1996 Mar; 8(3):307-315. PubMed ID: 8671616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.